Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 05-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100 | 830 | 1,750 | 900 | N/A |
| Other current assets | 330 | 460 | 500 | 390 | 0 |
| TOTAL | $430 | $1,290 | $2,250 | $1,290 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 600 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $600 | $N/A |
| Total Assets | $490 | $1,360 | $2,340 | $1,990 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 110 | 350 | 170 | 210 | 0 |
| Accrued Expenses | 1,140 | 1,080 | 1,060 | 930 | N/A |
| TOTAL | $1,550 | $1,430 | $1,240 | $1,150 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,550 | $1,430 | $1,240 | $1,150 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 3 |
| Common Shares | 167,960 | 167,620 | 175,010 | 167,820 | N/A |
| Retained earnings | -191,060 | -189,660 | -196,490 | -188,040 | N/A |
| Other shareholders' equity | 2,360 | 2,390 | 2,940 | 2,190 | 0 |
| TOTAL | $-1,050 | $-60 | $1,090 | $840 | $N/A |
| Total Liabilities And Equity | $500 | $1,370 | $2,330 | $1,990 | $0 |